Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation
To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT). Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT0...
Gespeichert in:
Veröffentlicht in: | Urology (Ridgewood, N.J.) N.J.), 2022-12, Vol.170, p.146-153 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 153 |
---|---|
container_issue | |
container_start_page | 146 |
container_title | Urology (Ridgewood, N.J.) |
container_volume | 170 |
creator | Imber, Brandon S. O'Dwyer, Elisabeth Lobaugh, Stephanie McBride, Sean M. Hopkins, Margaret Kollmeier, Marisa Gorovets, Daniel Brennan, Victoria Pike, Luke R.G. Gewanter, Richard Mychalczak, Borys Zhang, Zhigang Schöder, Heiko Zelefsky, Michael J. |
description | To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT).
Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression.
We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment.
Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies. |
doi_str_mv | 10.1016/j.urology.2022.08.035 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10576466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429522007798</els_id><sourcerecordid>2715441279</sourcerecordid><originalsourceid>FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</originalsourceid><addsrcrecordid>eNqFUcFu1DAQtRCILoVPAPnIJenYTpzkhKpVC0itWLXlbM0648WrbFzsZKX9e1x1WeDEZUaamfdm5j3G3gsoBQh9sS3nGIawOZQSpCyhLUHVL9hC1LIpuq6rX7IFQAdFJbv6jL1JaQsAWuvmNTtTWoi6knrB-mv0wxyJr3CaKI6Jrw98dX97yVdXD9yFyO_IzjHSOPFVDGnCifgSR0uRo8uIU9VOYXfgOPb8Hoc9bojfYe9x8mF8y145HBK9O-Zz9v366mH5pbj59vnr8vKmsErpqajJgWpl1ZHDWrlKNVitUYJb5380gCUNTZtjU6HVtFaidT3lguyr3qlGnbNPz7yP83pHvc1HRxzMY_Q7jAcT0Jt_O6P_YTZhbwTUja60zgwfjwwx_JwpTWbnk6VhwJHCnIxssm6VkE2XR-vnUZsFSJHcaY8A82SR2ZqjRebJIgOtyRZl3Ie_jzyhfnvy5wvKUu09RZOsp6x472NW2fTB_2fFL4n4p6c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2715441279</pqid></control><display><type>article</type><title>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Imber, Brandon S. ; O'Dwyer, Elisabeth ; Lobaugh, Stephanie ; McBride, Sean M. ; Hopkins, Margaret ; Kollmeier, Marisa ; Gorovets, Daniel ; Brennan, Victoria ; Pike, Luke R.G. ; Gewanter, Richard ; Mychalczak, Borys ; Zhang, Zhigang ; Schöder, Heiko ; Zelefsky, Michael J.</creator><creatorcontrib>Imber, Brandon S. ; O'Dwyer, Elisabeth ; Lobaugh, Stephanie ; McBride, Sean M. ; Hopkins, Margaret ; Kollmeier, Marisa ; Gorovets, Daniel ; Brennan, Victoria ; Pike, Luke R.G. ; Gewanter, Richard ; Mychalczak, Borys ; Zhang, Zhigang ; Schöder, Heiko ; Zelefsky, Michael J.</creatorcontrib><description>To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT).
Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression.
We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment.
Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2022.08.035</identifier><identifier>PMID: 36115426</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Neoplasm Recurrence, Local - surgery ; Positron Emission Tomography Computed Tomography - methods ; Positron-Emission Tomography ; Prospective Studies ; Prostate-Specific Antigen ; Prostatectomy ; Prostatic Neoplasms - diagnostic imaging ; Prostatic Neoplasms - radiotherapy ; Prostatic Neoplasms - surgery ; Salvage Therapy - methods ; Tomography, X-Ray Computed</subject><ispartof>Urology (Ridgewood, N.J.), 2022-12, Vol.170, p.146-153</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</citedby><cites>FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</cites><orcidid>0000-0002-1281-5915</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urology.2022.08.035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36115426$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Imber, Brandon S.</creatorcontrib><creatorcontrib>O'Dwyer, Elisabeth</creatorcontrib><creatorcontrib>Lobaugh, Stephanie</creatorcontrib><creatorcontrib>McBride, Sean M.</creatorcontrib><creatorcontrib>Hopkins, Margaret</creatorcontrib><creatorcontrib>Kollmeier, Marisa</creatorcontrib><creatorcontrib>Gorovets, Daniel</creatorcontrib><creatorcontrib>Brennan, Victoria</creatorcontrib><creatorcontrib>Pike, Luke R.G.</creatorcontrib><creatorcontrib>Gewanter, Richard</creatorcontrib><creatorcontrib>Mychalczak, Borys</creatorcontrib><creatorcontrib>Zhang, Zhigang</creatorcontrib><creatorcontrib>Schöder, Heiko</creatorcontrib><creatorcontrib>Zelefsky, Michael J.</creatorcontrib><title>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT).
Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression.
We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment.
Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies.</description><subject>Gallium Isotopes</subject><subject>Gallium Radioisotopes</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Positron-Emission Tomography</subject><subject>Prospective Studies</subject><subject>Prostate-Specific Antigen</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - diagnostic imaging</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Salvage Therapy - methods</subject><subject>Tomography, X-Ray Computed</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUcFu1DAQtRCILoVPAPnIJenYTpzkhKpVC0itWLXlbM0648WrbFzsZKX9e1x1WeDEZUaamfdm5j3G3gsoBQh9sS3nGIawOZQSpCyhLUHVL9hC1LIpuq6rX7IFQAdFJbv6jL1JaQsAWuvmNTtTWoi6knrB-mv0wxyJr3CaKI6Jrw98dX97yVdXD9yFyO_IzjHSOPFVDGnCifgSR0uRo8uIU9VOYXfgOPb8Hoc9bojfYe9x8mF8y145HBK9O-Zz9v366mH5pbj59vnr8vKmsErpqajJgWpl1ZHDWrlKNVitUYJb5380gCUNTZtjU6HVtFaidT3lguyr3qlGnbNPz7yP83pHvc1HRxzMY_Q7jAcT0Jt_O6P_YTZhbwTUja60zgwfjwwx_JwpTWbnk6VhwJHCnIxssm6VkE2XR-vnUZsFSJHcaY8A82SR2ZqjRebJIgOtyRZl3Ie_jzyhfnvy5wvKUu09RZOsp6x472NW2fTB_2fFL4n4p6c</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Imber, Brandon S.</creator><creator>O'Dwyer, Elisabeth</creator><creator>Lobaugh, Stephanie</creator><creator>McBride, Sean M.</creator><creator>Hopkins, Margaret</creator><creator>Kollmeier, Marisa</creator><creator>Gorovets, Daniel</creator><creator>Brennan, Victoria</creator><creator>Pike, Luke R.G.</creator><creator>Gewanter, Richard</creator><creator>Mychalczak, Borys</creator><creator>Zhang, Zhigang</creator><creator>Schöder, Heiko</creator><creator>Zelefsky, Michael J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1281-5915</orcidid></search><sort><creationdate>20221201</creationdate><title>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</title><author>Imber, Brandon S. ; O'Dwyer, Elisabeth ; Lobaugh, Stephanie ; McBride, Sean M. ; Hopkins, Margaret ; Kollmeier, Marisa ; Gorovets, Daniel ; Brennan, Victoria ; Pike, Luke R.G. ; Gewanter, Richard ; Mychalczak, Borys ; Zhang, Zhigang ; Schöder, Heiko ; Zelefsky, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c336t-5ef038249efa53f437a4ba20fb999600ce6078ce674ac6eb318fde8ce2d4df373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Gallium Isotopes</topic><topic>Gallium Radioisotopes</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Positron-Emission Tomography</topic><topic>Prospective Studies</topic><topic>Prostate-Specific Antigen</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - diagnostic imaging</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Salvage Therapy - methods</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Imber, Brandon S.</creatorcontrib><creatorcontrib>O'Dwyer, Elisabeth</creatorcontrib><creatorcontrib>Lobaugh, Stephanie</creatorcontrib><creatorcontrib>McBride, Sean M.</creatorcontrib><creatorcontrib>Hopkins, Margaret</creatorcontrib><creatorcontrib>Kollmeier, Marisa</creatorcontrib><creatorcontrib>Gorovets, Daniel</creatorcontrib><creatorcontrib>Brennan, Victoria</creatorcontrib><creatorcontrib>Pike, Luke R.G.</creatorcontrib><creatorcontrib>Gewanter, Richard</creatorcontrib><creatorcontrib>Mychalczak, Borys</creatorcontrib><creatorcontrib>Zhang, Zhigang</creatorcontrib><creatorcontrib>Schöder, Heiko</creatorcontrib><creatorcontrib>Zelefsky, Michael J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Imber, Brandon S.</au><au>O'Dwyer, Elisabeth</au><au>Lobaugh, Stephanie</au><au>McBride, Sean M.</au><au>Hopkins, Margaret</au><au>Kollmeier, Marisa</au><au>Gorovets, Daniel</au><au>Brennan, Victoria</au><au>Pike, Luke R.G.</au><au>Gewanter, Richard</au><au>Mychalczak, Borys</au><au>Zhang, Zhigang</au><au>Schöder, Heiko</au><au>Zelefsky, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>170</volume><spage>146</spage><epage>153</epage><pages>146-153</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>To characterize patterns of failure using prostate-specific membrane antigen positron emission tomography (PSMA PET) after radical prostatectomy (RP) and salvage radiotherapy (SRT).
Patients with rising PSA post-RP+SRT underwent 68Ga‐HBED‐iPSMA PET/CT on a single-arm, prospective imaging trial (NCT03204123). Scans were centrally reviewed with pattern-of-failure analysis by involved site. Positive scans were classified using 3 failure categories: pelvic nodal, extra-pelvic nodal or distant non-nodal. Associations with failure categories were analyzed using cumulative incidence and generalized logits regression.
We included 133 men who received SRT a median of 20 months post-RP; 56% received SRT to the prostatic fossa alone, while 44% received pelvic SRT. PSMA PET/CT was performed a median of 48 months post-SRT. Overall, 31% of PSMA PET/CT scans were negative, 2% equivocal and 67% had at least 1 positive site. Scan detection was significantly associated with PSA level prior to PSMA PET/CT. Analysis of 89 positive scans demonstrated pelvic nodal (53%) was the most common relapse and fossa relapse was low (9%). Overall, positive scans were pelvic (n = 35, 26%), extra-pelvic nodal (n = 26, 20%) or distant non-nodal failure (n = 28, 21%), and 70% of positive scans were oligorecurrent. We observed similar cumulative incidence for all failure categories and relatively few clinicodemographic associations. Men treated with pelvic SRT had reduced odds of pelvic failure versus exclusive fossa treatment.
Pelvic, extra-pelvic nodal, and distant non-nodal failures occur with similar incidence post-SRT. Regional nodal relapse is relatively common, especially with fossa-only SRT. A high oligorecurrence rate suggests a potentially important role for PSMA-guided focal therapies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36115426</pmid><doi>10.1016/j.urology.2022.08.035</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1281-5915</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-4295 |
ispartof | Urology (Ridgewood, N.J.), 2022-12, Vol.170, p.146-153 |
issn | 0090-4295 1527-9995 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10576466 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Gallium Isotopes Gallium Radioisotopes Humans Male Neoplasm Recurrence, Local - surgery Positron Emission Tomography Computed Tomography - methods Positron-Emission Tomography Prospective Studies Prostate-Specific Antigen Prostatectomy Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - surgery Salvage Therapy - methods Tomography, X-Ray Computed |
title | Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A02%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Failure%20Patterns%20by%20PSMA%20PET%20for%20Recurrent%20Prostate%20Cancer%20after%20Prostatectomy%20and%20Salvage%20Radiation&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Imber,%20Brandon%20S.&rft.date=2022-12-01&rft.volume=170&rft.spage=146&rft.epage=153&rft.pages=146-153&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2022.08.035&rft_dat=%3Cproquest_pubme%3E2715441279%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2715441279&rft_id=info:pmid/36115426&rft_els_id=S0090429522007798&rfr_iscdi=true |